DI LEO, Alfredo
 Distribuzione geografica
Continente #
NA - Nord America 21.113
AS - Asia 7.670
EU - Europa 5.678
SA - Sud America 1.962
AF - Africa 302
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 36.753
Nazione #
US - Stati Uniti d'America 20.855
SG - Singapore 3.237
CN - Cina 1.695
BR - Brasile 1.591
RU - Federazione Russa 1.544
HK - Hong Kong 946
SE - Svezia 881
DE - Germania 714
IT - Italia 588
VN - Vietnam 517
FR - Francia 390
UA - Ucraina 359
GB - Regno Unito 357
FI - Finlandia 355
IN - India 237
BD - Bangladesh 169
AR - Argentina 136
ID - Indonesia 122
IQ - Iraq 120
CA - Canada 112
BE - Belgio 102
TR - Turchia 96
ZA - Sudafrica 78
MX - Messico 75
PL - Polonia 73
CO - Colombia 67
PK - Pakistan 65
JP - Giappone 57
ES - Italia 56
UZ - Uzbekistan 53
PH - Filippine 52
SA - Arabia Saudita 50
NL - Olanda 49
EC - Ecuador 48
CI - Costa d'Avorio 45
IE - Irlanda 42
MA - Marocco 40
VE - Venezuela 40
TN - Tunisia 29
JO - Giordania 28
AT - Austria 27
KE - Kenya 27
CL - Cile 24
MY - Malesia 24
RO - Romania 23
CZ - Repubblica Ceca 22
EG - Egitto 22
PY - Paraguay 22
AE - Emirati Arabi Uniti 20
PE - Perù 19
DZ - Algeria 18
IR - Iran 18
KZ - Kazakistan 18
AL - Albania 17
AZ - Azerbaigian 17
IL - Israele 17
AU - Australia 14
LB - Libano 13
NP - Nepal 13
ET - Etiopia 12
GT - Guatemala 12
LT - Lituania 11
CR - Costa Rica 10
TH - Thailandia 10
KR - Corea 9
QA - Qatar 9
BO - Bolivia 8
GR - Grecia 8
JM - Giamaica 8
OM - Oman 8
PA - Panama 8
PS - Palestinian Territory 8
TW - Taiwan 8
BG - Bulgaria 7
KG - Kirghizistan 7
NI - Nicaragua 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
CH - Svizzera 6
EU - Europa 6
KW - Kuwait 6
UY - Uruguay 6
AO - Angola 5
BB - Barbados 5
GA - Gabon 5
GE - Georgia 5
LV - Lettonia 5
MD - Moldavia 5
MK - Macedonia 5
DO - Repubblica Dominicana 4
HN - Honduras 4
SN - Senegal 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BW - Botswana 3
BY - Bielorussia 3
EE - Estonia 3
LU - Lussemburgo 3
MU - Mauritius 3
Totale 36.708
Città #
Fairfield 2.600
Ashburn 2.010
Woodbridge 1.918
Singapore 1.794
Chandler 1.385
Houston 1.281
Seattle 1.064
San Jose 967
Hong Kong 940
Cambridge 904
Ann Arbor 863
Wilmington 820
Jacksonville 819
Nyköping 704
Dallas 595
Beijing 539
New York 346
Lawrence 292
Roxbury 286
Nanjing 254
Lauterbourg 252
Los Angeles 231
Bari 178
Des Moines 177
Council Bluffs 166
Dearborn 154
Ho Chi Minh City 140
Inglewood 138
São Paulo 137
Helsinki 135
Boardman 127
Princeton 126
Santa Clara 115
Brooklyn 112
Hanoi 110
Brussels 102
Munich 99
San Diego 89
Buffalo 82
Chicago 71
Jakarta 69
Nanchang 67
Frankfurt am Main 66
Shenyang 65
London 61
Moscow 61
Warsaw 59
Hebei 58
Dong Ket 55
Jiaxing 53
Tokyo 53
Atlanta 51
Rio de Janeiro 48
Johannesburg 47
Orem 47
Tashkent 46
The Dalles 46
Abidjan 45
Changsha 42
Columbus 42
Dublin 42
Falkenstein 42
Baghdad 41
Tianjin 41
Belo Horizonte 40
Nuremberg 40
Stockholm 39
Paris 38
Montreal 36
Dhaka 35
San Francisco 35
Pune 34
Chennai 32
Denver 32
Hefei 32
Boston 30
Haiphong 28
Toronto 28
Brasília 27
Curitiba 27
Mexico City 27
Milan 27
Porto Alegre 27
Amman 26
Medellín 26
Redwood City 26
Da Nang 25
Falls Church 25
Guangzhou 25
Manchester 25
Istanbul 24
Mumbai 24
Lahore 23
Nairobi 23
Shanghai 23
Zhengzhou 22
Ankara 21
Augusta 21
Salvador 21
Amsterdam 20
Totale 25.383
Nome #
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 777
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 218
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome? 211
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 210
Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection 207
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 204
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 203
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 201
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 201
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 200
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 195
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 195
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 195
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 190
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients 186
Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions 186
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 185
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 184
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 182
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 181
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 181
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 180
Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation 179
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 179
Anti-viral therapy in chronic HBV infection: a single centre experience. 177
Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial 171
Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study 170
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 169
A mysterious case of gastroparesis: could the secret be found in a drink? 165
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 165
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 162
Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident? 161
Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. 160
Antagonistic activity of potential probiotic Lactobacilli against the ureolytic pathogen Yersinia enterocolitica 159
Serum fructosamine and colorectal adenomas 158
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. 158
Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence 156
Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. 155
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 155
Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma 155
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients 154
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 154
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 154
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 153
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 153
Lesson from an intriguing case of cryoglobulinemia 153
Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions 153
Estrogens, phytoestrogens and colorectal neoproliferative lesions 151
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 151
Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1) 150
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 150
The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. 149
Curcumin and colorectal cancer: From basic to clinical evidences 148
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 147
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 146
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 146
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 145
Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice 144
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 144
Evaluation of non-celiac gluten sensitivity in patients with previous diagnosis of irritable bowel syndrome: A randomized double-blind placebo-controlled crossover trial 144
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 142
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma 140
H. pylori status and angiogenesis factors in human gastric carcinoma 139
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 139
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 139
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 138
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 138
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy 137
Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice 137
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. 136
Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a) 136
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 136
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 134
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 134
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 134
Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: an easy, reliable and non-invasive procedure 133
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 133
Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice 133
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. 131
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 131
Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics 130
Celiac disease and common variable immunodeficiency: a familial inheritance? 130
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 130
Survival after the diagnosis of de novo malignancy in liver transplant recipients 128
Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage 127
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori 127
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 126
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 126
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 126
The association between cardiac and gastrointestinal disorders: causal or casual link? 125
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 125
Circadian rhythm of hepatic cytosolic and nuclear estrogen receptors. 123
Estrogen receptor beta as target for colorectal cancer prevention 123
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 122
In vitro gallbladder motility in patients with radiolucent and radiopaque stones. 121
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy. 121
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 121
Improved efficacy of 10-Day sequential treatment for Helicobacter Pylori eradication in children: a randomized trial 121
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 121
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 121
Totale 16.029
Categoria #
all - tutte 148.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021991 0 0 0 0 0 0 0 0 0 484 257 250
2021/20222.125 127 187 55 99 110 178 82 132 142 157 350 506
2022/20233.490 491 429 243 287 383 491 35 402 553 21 95 60
2023/20241.218 104 229 52 113 91 350 29 39 8 57 15 131
2024/20255.367 125 78 407 135 154 477 638 544 266 300 782 1.461
2025/202611.596 1.752 569 1.054 1.173 1.439 606 1.431 373 2.164 1.035 0 0
Totale 37.826